Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Strong Drop is a brand line of medical cannabis flower products developed and distributed by the German pharmaceutical company DEMECAN. The product line includes several high-THC (typically around 26-27% THC and <1% CBD) cultivars, such as RS-11 (Rainbow Sherbert #11), Holly Roller #11, Purple Octane, Girl Scout Kush, Lava Cake, and Sky Pie. These unirradiated medical cannabis flowers are cultivated under strict pharmaceutical standards (primarily in Germany and Canada) and are prescribed for inhalation or oral administration (e.g., tea). Strong Drop is primarily used in medical cannabis therapy to treat chronic pain, spasticity associated with multiple sclerosis, chemotherapy-induced nausea and vomiting, sleep disorders, anxiety, and depression. The therapeutic effects are mediated by the active cannabinoids, primarily tetrahydrocannabinol (THC), which acts as a partial agonist at cannabinoid receptors CB1 and CB2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Strong Drop.